Higher doses of semaglutide can safely enhance weight loss for adults living with obesity, clinical trials confirm

Drug firm publishes clinical trials tripling Ozempic dose for greater weight loss

The higher dose could be a new option for people who have struggled to lose weight, but more research is needed on long-term effects.

Wegovy jabs at a higher dose help people lose a quarter of their body weight - The Mirror

A new study suggests higher doses of popular weight loss jabs are ‘safe’ and could be offered soon to help people shed more pounds

Higher doses of semaglutide can safely enhance weight loss for adults living with obesity, clinical trials confirm

A higher weekly dose of semaglutide (7.2 mg) can significantly improve weight loss and related health outcomes in adults living with obesity, including those with type 2 diabetes (T2D), according to the results of two large-scale, international phase 3 clinical trials.

Higher doses of semaglutide safe, can aid in better weight loss for obese adults: Study

New Delhi, Sep 15 (SocialNews.XYZ) A higher weekly dose of semaglutide (7.2 mg) is safe and can significantly improve weight loss in adults living with obesity, including those with type 2 diabetes (T2D), according to an international study, published on Monday. The findings, based on results of two large-scale, international phase 3 clinical trials and published in The Lancet Diabetes & Endocrinology journal, suggest that a higher dose of semag…

expert reaction to two studies on higher doses of semaglutide and weight loss for adults living with obesity

Two studies published in The Lancet Diabetes & Endocrinology looks at the effect of higher doses of semaglutide on weight loss in adults with obesity.    Prof Lora Heisler, Director of Research, Rowett Institute, University of Aberdeen, Rowett Institute, University of Aberdeen, said: “This study investigated whether a once weekly injection with a higher dose of semaglutide (the active ingredient of Wegovy and Ozempic) produced greater therapeuti…

Higher Dose of Semaglutide Enhances Weight Loss Effects Safely

Results from two late-stage clinical trials show that tripling the standard dose of semaglutide can significantly increase weight loss in individuals with obesity, both with or without a type 2 diabetes diagnosis. Published back to back in The Lancet Diabetes & Endocrinology, results from both trials show that a higher dose of this drug could help those who have not been able to achieve sufficient weight loss with other existing treatments.   Se…